States are using Preferred Drug Lists, copay differentials, and pharmacist substitution rules to push patients toward cheaper generic drugs. These policies save billions - but sustainability challenges loom as rebate systems threaten generic availability.
Pharmacokinetic studies are the backbone of generic drug approval, proving that generics behave like brand-name drugs in the body. But they're not perfect-especially for complex formulations. Here's how they work, where they fall short, and what's changing.
Pharmacy delivery and mail-order services make it easier to stick to your medication schedule by offering 90-day supplies delivered to your door. Save money, reduce trips, and improve adherence-especially for chronic conditions.
Pharmacists must stay current on generics to ensure safe substitutions, comply with state laws, and avoid malpractice. Learn the latest FDA requirements, ACPE standards, and practical CE strategies for 2026.
Learn how to use CGM trend arrows to adjust diabetes medication doses safely and prevent dangerous highs and lows. Proven methods from the Endocrine Society help you act before glucose crashes or spikes.
QD and QID are dangerous prescription abbreviations that cause deadly dosing errors. Learn how they're misread, who's most at risk, and what you can do to prevent them - whether you're a patient or a healthcare worker.
Learn how to prevent dangerous high potassium levels while taking ACE inhibitors. Discover which foods to avoid, safe alternatives, testing schedules, and practical tips to stay healthy without giving up nutritious meals.
Learn how Medicare Part D formularies cover generic drugs in 2025, including cost tiers, the $2,000 out-of-pocket cap, how to save money, and what's changing next year.
Secondary patents let drug companies extend monopolies by patenting minor changes like pill form or new uses-delaying generics and keeping prices high. Learn how this strategy works, who it hurts, and where it’s being challenged.
Biosimilars work just as well as original biologics for cancer, arthritis, and autoimmune diseases. Learn how clinical data, real-world outcomes, and cost savings support their use-and why adoption still faces barriers.
